Interview: A career spanning from heart failure to preventative cardiology and lipidology. (April 2014)

• Record Type: Journal Article
• Authors: Deedwania, Prakash C
• Is Part Of: Clinical lipidology. Volume 9:Number 2(2014)
• Page Start: 145
• Page End: 148
• Publication Date: 2014-04
• Subjects: coronary disease -- diabetes -- lipoproteins -- preventive cardiology -- south Asians; Lipids -- Periodicals; 616.3997
• DOI: 10.2217/clp.14.5
• Languages: English
• ISSNs: 1758-4299

Abstract

Prakash C Deedwania* speaks to Simi Thankaraj, Assistant Commissioning Editor: Prakash C Deedwania, MD, FACC, FAHA, FACP, FCCP, is Professor of Medicine at the University of California–San Francisco (UCSF) School of Medicine (CA, USA), Chief of the Cardiology Division for the Veterans Administration Central California Health Care System/UCSF Program in Fresno (CA, USA), Director of Cardiovascular Research for the UCSF Fresno–Central San Joaquin Valley Medical Education Program and Clinical Professor of Medicine at Stanford University in Palo Alto (CA, USA). Dr Deedwania is a fellow of the American Heart Association (AHA), American College of Cardiology (ACC), American College of Chest Physician and American College of Physician, and a member of the American Thoracic Society, American Federation of Clinical Research, Council on Silent Myocardial Ischemia and Infarction, International Society of Ambulatory Science and New York Trudeau Society. He has served as Chair of the Executive Committee of the Laennec Society of the AHA and is currently President of the California Chapter of the American Society of Hypertension and is Past President of the International Society for Holter and Noninvasive Electrocardiology. He is a member of several writing groups, including the ACC/AHA Practice Guidelines on Chronic Stable Angina and Ambulatory ECG Monitoring. Dr Deedwania also serves on the Practice Guidelines Committee of the Heart Failure Society of America and recently served on the joint writing group of AHA/American Diabetes Association (ADA)/ACC for the position statement on intensive glucose control in patients with diabetes. Dr Deedwania has authored numerous landmark clinical trials, has authored or coauthored more than 350 publications and serves on the editorial boards of numerous journals, and lectures regularly both nationally and internationally.